An article published Online First in The Lancet Oncology reports that zoledronic acid, which is a bone strengthening drug, when given together with chemotherapy might decrease the spread of cancer in women with locally advanced breast cancer. It reduces the likelihood of tumour cells growing in bone marrow and spreading to other parts of the body...
More...
Linear Mode
